Evidence map›Paper›PMID 42361346›Full record

ArticleBlood advances2026

E-lesion or stage IV disease? An ongoing unsettled issue in pediatric Hodgkin lymphoma.

Jennifer Seelisch, Christine Mauz-Koerholz, Kara M Kelly, Michael Link, Angela Punnett, Dietrich Stoevesandt, Monica Palese, Sue Kaste, Kathleen McCarten, Lars Kurch and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jennifer SeelischPediatric Hematology/Oncology, Children's Hospital London Health Sciences Centre, London, ON, Canada.ORCID 0000-0002-2187-0051
Christine Mauz-KoerholzDepartment of Pediatric Hematology and Oncology, Justus-Liebig University Giessen, Giessen, Germany.ORCID 0000-0002-8205-8665
Kara M KellyRoswell Park Comprehensive Cancer Center, Buffalo, NY.
Michael LinkDivision of Pediatric Hematology and Oncology, Department of Pediatrics, Stanford University, Stanford, CA.
Angela PunnettDivision of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Dietrich StoevesandtDepartment of Radiology, University Hospital Halle, Halle/Salle, Germany.
Monica PaleseDivision of Pediatric Hematology/Oncology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY.
Sue KasteDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN.
Kathleen McCartenPediatric Radiology, Imaging and Radiation Oncology Core-Rhode Island, Lincoln, RI.ORCID 0009-0002-2580-4171
Lars KurchDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0002-3396-4880
Bradford HoppeDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL.ORCID 0000-0002-2312-5418
Jamie E FlerlageDepartment of Pediatrics, Hematology and Oncology, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-4182-9355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42361346
PMCPMC13544170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.